Unveiling CCR9 and CCL13 as immune biomarkers and therapeutic targets in thymoma.

Sci Rep · 2025 · PMC12789674 · PMID 41353468

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the validation cohort, expression levels of all three candidate biomarkers were found to be lower in tumor samples (thymic carcinoid and thymoma) compared to the control group; however, CX3CL1 did not reach statistical significance (Fig. 4 C).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.